US Patent Issued to Boehringer Ingelheim International on Dec. 23 for "Use of anti-IL-36R antibodies for treatment of generalized pustular psoriasis" (German Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,512, issued on Dec. 23, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Use of anti-IL-36R antibodies for treatment of generalized pustular psoriasis" was invented by Christian Thoma (Biberach an der Riss, Germany), Steven John Padula (Wiesbaden, Germany) and Janine Lamar (Ingelheim am Rhein, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides specific dosage regimens for the treatment of generalized pustular psoriasis (GPP) with anti-interleukin-36R antibodies (anti-IL36R antibodies) which dosage regimens surprisingly provide for the rapid and sustained remission of pathologi...